Galectin Therapeutics (GALT) Net Income towards Common Stockholders Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -58.11% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -95.76% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -290.15% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 59.59% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | -129.68% |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -10.08% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 1,228.66% |
| 10 | Galectin Therapeutics | 165.77 Mn | 151.67 Mn | - | 47.25% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 47.25% |
| Dec 31, 2025 | 53.77% |
| Sep 30, 2025 | 26.83% |
| Jun 30, 2025 | 39.01% |
| Mar 31, 2025 | 16.46% |
| Dec 31, 2024 | -19.58% |
| Sep 30, 2024 | 19.96% |
| Jun 30, 2024 | -35.50% |
| Mar 31, 2024 | 0.26% |
| Dec 31, 2023 | 5.97% |
| Sep 30, 2023 | -63.63% |
| Jun 30, 2023 | 5.17% |
| Mar 31, 2023 | -16.25% |
| Dec 31, 2022 | -46.80% |
| Sep 30, 2022 | -0.28% |
| Jun 30, 2022 | -13.66% |
| Mar 31, 2022 | -56.40% |
| Dec 31, 2021 | 7.94% |
| Sep 30, 2021 | -43.69% |
| Jun 30, 2021 | -37.77% |
| Mar 31, 2021 | -78.59% |
| Dec 31, 2020 | -52.19% |
| Sep 30, 2020 | -111.25% |
| Jun 30, 2020 | -101.63% |
| Mar 31, 2020 | 60.96% |
| Dec 31, 2019 | -55.33% |
| Sep 30, 2019 | 7.45% |
| Jun 30, 2019 | 25.39% |
| Mar 31, 2019 | -100.15% |
| Dec 31, 2018 | -20.17% |
| Sep 30, 2018 | 34.66% |
| Jun 30, 2018 | 14.58% |
| Mar 31, 2018 | 12.79% |
| Dec 31, 2017 | 42.73% |
| Sep 30, 2017 | -0.37% |
| Jun 30, 2017 | 17.47% |
| Mar 31, 2017 | 25.69% |
| Dec 31, 2016 | 2.03% |
| Sep 30, 2016 | 24.50% |
| Jun 30, 2016 | -18.17% |
| Mar 31, 2016 | -38.16% |
| Dec 31, 2015 | -25.18% |
| Sep 30, 2015 | -59.67% |
| Jun 30, 2015 | -32.16% |
| Mar 31, 2015 | 6.18% |
| Dec 31, 2014 | -27.55% |
| Sep 30, 2014 | -3.49% |
| Jun 30, 2014 | 67.95% |
| Mar 31, 2014 | -55.76% |
| Dec 31, 2013 | -14.88% |
| Sep 30, 2013 | -24.72% |
| Jun 30, 2013 | -290.11% |
| Mar 31, 2013 | -57.53% |
| Dec 31, 2012 | 27.17% |
| Sep 30, 2012 | -27.62% |
| Jun 30, 2012 | 24.15% |
| Mar 31, 2012 | 19.03% |
| Dec 31, 2011 | -144.93% |
| Sep 30, 2011 | -23.17% |
| Jun 30, 2011 | -58.95% |